Fresh Rounds

Intercure Ltd. funding

Intercure Ltd., a pharmaceuticals company based in Hertzliya, Israel, filed a Form D with the SEC on August 19, 2026 and reported a open-ended offering.

Amount raised$0
Offering sizeOpen-ended
Filed with the SECAugust 19, 2026
First saleJune 15, 2026
IndustryPharmaceuticals
SecuritiesEquity, Options or warrants
LocationHertzliya, Israel
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far15
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds